Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevelamer versus calcium carbonate on serum magnesium in hemodialysis patients
IRCT20180831040912N1Phase 3Completed
- Sponsor
- Semnan University of Medical Sciences
- Start
- Oct 2018
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in chronic kidney disease (CKD) and hyperphosphatemia comparing Sevelamer with Calcium carbonate (2 arms). Primary endpoint: Serum magnesium level. Started Oct 2018; status: completed.
02
Drugs
sevelamer carbonatecalcium carbonate
03
Conditions
chronic kidney disease (CKD)hyperphosphatemia
Beyond the preview
Go deeper on IRCT20180831040912N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180831040912N1.